Immune Checkpoint Inhibitors Alone vs Immune Checkpoint Inhibitors—Combined Chemotherapy for NSCLC Patients with High PD-L1 Expression: A Network Meta-Analysis

The authors indirectly compared the effects of immune checkpoint inhibitors alone (ICI) and ICI-combined chemotherapy in patients with non-small cell lung cancer who had high programmed death-ligand 1 (PD-L1) expression through network meta-analyses.